Drug Enforcement D-0126-2025

Superpotent Drug and Subpotent Drug: potency failures obtained

Status

Ongoing

Classification

Class II

Report Date

December 18, 2024

Termination Date

—

Product Information

Product description
Levothyroxine Sodium Tablets USP, 88 mcg, packaged in a) 90-count bottles (NDC 0378-1807-77) and b) 1000-count bottles (NDC 0378-1807-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.
Product quantity
43,765 bottles
Reason for recall
Superpotent Drug and Subpotent Drug: potency failures obtained
Recall initiation reason
—
Initial firm notification
Letter
Distribution pattern
Nationwide within the United States and Puerto Rico

Location & Firm

Recalling firm
Viatris Inc
Address
1000 Mylan Blvd

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date
—

Codes & Dates

Recall number
D-0126-2025
Event ID
95768
Recall initiation date
November 18, 2024
Center classification date
December 12, 2024
Code info
Lot # a) 8180781, Exp. Date Aug 2025; b)3191628, Exp. Date Feb 2025; 3197139, Exp. Date Apr 2025; 3188976, Exp. Date Jan 2025; 3184929, Exp. Date Dec 2024; 3204909, Exp. Date Aug 2025
More code info
—